BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22340721)

  • 1. Protein tyrosine phosphatases in cancer: friends and foes!
    Labbé DP; Hardy S; Tremblay ML
    Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatases: from genes, to function, to disease.
    Tonks NK
    Nat Rev Mol Cell Biol; 2006 Nov; 7(11):833-46. PubMed ID: 17057753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.
    Denu JM; Tanner KG
    Biochemistry; 1998 Apr; 37(16):5633-42. PubMed ID: 9548949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Checks and balances: interplay of RTKs and PTPs in cancer progression.
    Sastry SK; Elferink LA
    Biochem Pharmacol; 2011 Sep; 82(5):435-40. PubMed ID: 21704606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative and apoptosis-inducing effects of an antitumor glycoprotein from Streptococcus pyogenes.
    Yoshida J; Takamura S; Ishibashi T; Nishio M
    Anticancer Res; 1999; 19(3A):1865-71. PubMed ID: 10470129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicological disruption of signaling homeostasis: tyrosine phosphatases as targets.
    Samet JM; Tal TL
    Annu Rev Pharmacol Toxicol; 2010; 50():215-35. PubMed ID: 20055703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphatases in vessel wall signaling.
    Kappert K; Peters KG; Böhmer FD; Ostman A
    Cardiovasc Res; 2005 Feb; 65(3):587-98. PubMed ID: 15664385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
    Suárez Pestana E; Tenev T; Gross S; Stoyanov B; Ogata M; Böhmer FD
    Oncogene; 1999 Jul; 18(28):4069-79. PubMed ID: 10435588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatases and signalling.
    Stoker AW
    J Endocrinol; 2005 Apr; 185(1):19-33. PubMed ID: 15817824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of oncogenic protein tyrosine phosphatases in cancer.
    Hardy S; Julien SG; Tremblay ML
    Anticancer Agents Med Chem; 2012 Jan; 12(1):4-18. PubMed ID: 21707506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease.
    Pulido R; Stoker AW; Hendriks WJ
    Hum Mol Genet; 2013 Oct; 22(R1):R66-76. PubMed ID: 23900072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-tyrosine phosphatases and cancer.
    Ostman A; Hellberg C; Böhmer FD
    Nat Rev Cancer; 2006 Apr; 6(4):307-20. PubMed ID: 16557282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the role of Src and protein-tyrosine phosphatases balance in modulating osteoblast metabolism: lessons from mice.
    Zambuzzi WF; Milani R; Teti A
    Biochimie; 2010 Apr; 92(4):327-32. PubMed ID: 20083150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
    Florio T
    Mol Cell Endocrinol; 2008 May; 286(1-2):40-8. PubMed ID: 17913342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRL PTPs: mediators and markers of cancer progression.
    Bessette DC; Qiu D; Pallen CJ
    Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
    Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
    Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011).
    Sobhia ME; Paul S; Shinde R; Potluri M; Gundam V; Kaur A; Haokip T
    Expert Opin Ther Pat; 2012 Feb; 22(2):125-53. PubMed ID: 22332719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.